Ebos Group Ltd

EBO

Company Profile

  • Business description

    Ebos is the second-largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

  • Contact

    737 Bourke Street
    Level 7
    Docklands
    MelbourneVIC3008
    AUS

    T: +61 399185555

    E: [email protected]

    https://www.ebosgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    30 June 2026

    Employees

    5,700

Stocks News & Analysis

stocks

Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing

North America was a notable blemish, down 2% on an organic basis.
stocks

Our view on Santos after production is ramped up

Barossa at 75% capacity and Pikka undergoing commissioning.
stocks

GE Aerospace earnings: No good deed goes unpunished

We’ve raised our fair value estimate of GE Aerospace stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,210.7036.500.40%
CAC 408,148.8979.720.99%
DAX 4024,856.47295.491.20%
Dow JONES (US)49,384.01306.780.63%
FTSE 10010,150.0511.960.12%
HKSE26,797.07167.110.63%
NASDAQ23,436.02211.200.91%
Nikkei 22553,851.87162.980.30%
NZX 50 Index13,498.5758.30-0.43%
S&P 5006,913.3537.730.55%
S&P/ASX 2008,880.3035.200.40%
SSE Composite Index4,136.4613.880.34%

Market Movers